• Latest Posts

European Biotechs Showcase Multiple Sclerosis Treatments in Stockholm

Blocking Hidden Viral Protein Shows Promise for Treating Multiple Sclerosis

More News! 26 Mar 2018

Attacking an Ancient Virus Slows Multiple Sclerosis in Phase II

This Multiple Sclerosis Drug Could Help to Fight Another Autoimmune Disease

More News! 1 Nov 2017

Swiss Biotech & French Pharma Reverse Damage in Multiple Sclerosis

In Geneva, the Capital of Peace, 10 Biotechs Are Putting up a Fight


Interview: GeNeuro’s CFO explains its Unique Multiple Sclerosis Treatment

First Euronext Biotech IPO of 2016 is Swiss, and for Multiple Sclerosis!

Will there be a New Merck-Serono?